3Aikawa Y, Tanuma N, Shin T, et al. A new antirheumatic drug, T-614, effectively suppresses the development of autoimmune encephalomyelitis[J]. J Neuroimm, 1998, 89(1-2): 35-42.
4Jiang Y, Yu SQ. The role of nuclear transcription factor-B pathway in acute lung injury induced by endotoxin[J]. Chin J Crit Care Med, 2004, 24: 902-904.
5Sawada T, Hashimoto S, Tohma S, et al. Inhibition of l-leucine methyl ester mediated killing of THP-I, a human monocytic cell line, by a new anti-inflammatory drug, T614[J]. Immunopharmacology, 2000, 49(3): 285-294.
8Tanaka K, Uratal N, Mikami M, et al. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced caehexia in mice[J]. Inflamm Res, 2007, 56 (1) : 17-23.
9KeiferJ, Guttridge DC, Ashburner BP, et al. Inhibition of NF-kappa B activity by Thalidomide through Suppression of Ikappa B kinase Activity[J]. Biol Chem, 2001, 276(25): 22382-22387.
7Aikawa Y, Tanuma N, Shin T,et al. A new anti- rheumatic drug, T - 614, effectively suppresses the development of autoimmune encephalomyelitis. J Neuroimmunol, 1998,89 ( 1 - 2) :35 - 42.
8Tanaka K, Yamamoto T, Aikawa Y,et al. Inhibitory effects of an anti - rheumatic agent T -614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice. Rheumatology (Oxford) ,2003 ,42( 11 ) :1365 - 1371.
9Futaki N, Yoshikawa K, Hamasaka Y,et al. NS -398, a novel non - steroidal anti - inflammatory drug with potent analgesic and antipyretie effects, which causes minimal stomach lesions. Gen Pharmaeol, 1993, 24(1) :105 -110.
10Zamoiskii EA. Evaluation of Reed - Muench method in determination of activity of biological preparations. Zh Mikrobiol Epidemiol Immunohiol, 1956,27 ( 1 ) :77 - 83.
4Moerman RV,Arends S,Meiners PM,etal.EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial[J].Annals of the rheumatic diseases,2014,2(73):472-476.
5Luo Q,Sun Y,Liu W,et al.A novel disease-modifying antirheumatic drug,iguratimod,ameliorates murine arthritis by blocking IL-17 signaling,distinct from methotrexate and leflunomide[J].Journal of immunology (Baltimore,Md:1950)2013,191(10):4969-4978.
6Mucke HA.Iguratimod:a new disease-modifying antirheumatic drug[J].Drugs of today (Barcelona,Spain:1998),2012,48(9):577-586.
9Malviya A,Kuiper JH,Makwana N,et al.The effect of newer antirheumatic drug on osteogenic cell proliferation:an in vitro study[J].J Orthop Surg Res,2009,4(17):l-7.
